glp 1 agonist trade name 17. My DiabetesConnect: Know your Diabetic Medications GLP-1 Receptor Agonists and Other

Greenway, F.L

Does GLP-1 treatment lead to muscle loss

Ozempic and Wegovy created enormous brand recognition, and oral semaglutide gives Novo a major lever in the pill-based obesity market

On the evening of 20 March 2026, hours before Novo Nordisks Indian patent on semaglutide formally expired, Natco Pharma announced that its generic vial would sell for 1,290 a month

These re-dosed drugs are sold under the brand name Wegovy

The bottom line At the end of the day, microdosing GLP-1s is just a buzzy way of talking about a different approach to GLP-1s namely, starting (and staying) at the right dose for you, even if its lower than what the manufacturer recommends